A Computational Study of the Resistance of HIV-1 Aspartic Protease to the Inhibitors ABT-538 and VX-478 and Design of New Analogues
- 26 January 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 242 (3) , 545-551
- https://doi.org/10.1006/bbrc.1997.8008
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Mutational Anatomy of an HIV-1 Protease Variant Conferring Cross-resistance to Protease Inhibitors in Clinical TrialsJournal of Biological Chemistry, 1996
- Human Immunodeficiency VirusJournal of Biological Chemistry, 1996
- Kinetic Characterization of Human Immunodeficiency Virus Type-1 Protease-resistant VariantsJournal of Biological Chemistry, 1996
- Three-dimensional Structure of a Mutant HIV-1 Protease Displaying Cross-resistance to All Protease Inhibitors in Clinical TrialsPublished by Elsevier ,1995
- Kinetic Characterization and Cross-Resistance Patterns Of HIV-1 Protease Mutants Selected under Drug PressureBiochemistry, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and TherapyScience, 1995
- Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.Proceedings of the National Academy of Sciences, 1994
- In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease.Proceedings of the National Academy of Sciences, 1993
- High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapyThe Journal of Pediatrics, 1993